Dry eye symptoms in midlife women: A cross-sectional analysis of prevalence, risk factors, and quality-of-life outcomes

dc.contributor.authorVallibhakara S.A.O.
dc.contributor.authorChattrakulchai K.
dc.contributor.authorVallibhakara O.
dc.contributor.authorAnantaburana M.
dc.contributor.authorNijvipakul S.
dc.contributor.correspondenceVallibhakara S.A.O.
dc.contributor.otherMahidol University
dc.date.accessioned2025-09-11T18:18:56Z
dc.date.available2025-09-11T18:18:56Z
dc.date.issued2025-10-01
dc.description.abstractObjectives: To assess the prevalence, associated factors, and quality-of-life impact of dry eye symptoms among perimenopausal and postmenopausal women in Thailand. Study Design: This cross-sectional study, conducted from September to December 2024, included 262 women aged 41–60 years attending a gynaecology and menopause clinic at Ramathibodi Hospital. Participants completed the Ocular Surface Disease Index and the Menopause-Specific Quality of Life questionnaires. Multivariate logistic regression was used to identify factors associated with moderate to severe symptoms. Main outcome measures: The primary outcome was the prevalence of dry eye symptoms. Secondary outcomes included symptom severity, quality-of-life scores, and occupational or clinical risk factors for moderate to severe symptoms. Results: Dry eye symptoms were identified in 64.9 % of participants, with comparable rates in perimenopausal (61.7 %) and postmenopausal (68.2 %) women. No significant difference in symptom scores was observed between groups (p = 0.746). Computer-based work was independently associated with moderate to severe symptoms (adjusted odds ratio 1.81, 95 % CI 1.10–2.99). Women with more severe symptoms reported significantly poorer physical, psychological, and vasomotor quality-of-life scores. Conclusions: Dry eye symptoms are highly prevalent among midlife Thai women and negatively affect quality of life, particularly in the physical, psychological, and vasomotor domains. Occupational screen exposure is a significant modifiable risk factor. Early screening and targeted management may help reduce the impact of symptoms during the menopausal transition.
dc.identifier.citationMaturitas Vol.201 (2025)
dc.identifier.doi10.1016/j.maturitas.2025.108694
dc.identifier.eissn18734111
dc.identifier.issn03785122
dc.identifier.scopus2-s2.0-105014995034
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/112019
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleDry eye symptoms in midlife women: A cross-sectional analysis of prevalence, risk factors, and quality-of-life outcomes
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105014995034&origin=inward
oaire.citation.titleMaturitas
oaire.citation.volume201
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University

Files

Collections